Global Pulmonology Lasers Market To Witness Highest Market Share In North America

The global pulmonology lasers market size was worth around USD 4.3 billion in 2021 and is predicted to grow to around USD 6.45 billion by 2028 with a compound annual growth rate (CAGR) of roughly 12.15% between 2022 and 2028.

Pulmonology is the brand of medicine dealing with the diagnosis and treatment of lungs or other respiratory systems. With the advancement in technology and intensive research & development in the healthcare sector, it has now become relatively easier to treat rare and complex medical problems while also being attentive to patients' discomfort and overall experience.

Earlier due to a lack of tools, the chances of postoperative infections were very high. However, recent technologies like lasers amongst others have aided the reduction of unwanted scenarios like extra blood loss, postoperative pain, and infections. The use of lasers in pulmonology has acted as a boon to treat various respiratory disorders one of them being lung cancer. For instance, the Nd: YAG is a laser therapy that uses a focused beam of extremely powerful light energy which helps destroy airway cancers or any other form of abnormal growth in airway tissues along with effectively treating airway bleeding.

Some of the major benefits of the treatment involve empowering the surgeons to expedite the process of removal of infected airway tissues. It is one of several other endobronchial therapies that helps in removing airway tumors, granulation tissues, removal of tracheal stenosis, or photocoagulation of specific airway bleeding areas.

Covid-19 propelled the global pulmonology lasers market cap size owing to the impact the virus had on the lungs and airways of the infected patients. In the case of progressive Covid-19 induced pneumonia, air sacs were filled with fluid that leaked from the blood vessels located in the lungs. One of the most common and critical symptoms of Covid-19 was shortness of breath, and extreme breathlessness led to respiratory distress syndrome which is a form of lung failure. During the peak of the virus, pulmonologists were at the forefront of the medical treatment teams across regions.

The global pulmonology lasers market is projected to grow owing to the rising prevalence of lung cancer worldwide as well as the effectiveness of lasers in treating the condition. In laser therapies, an accurate and focused beam of light is used to destroy the cancerous cells, and this therapy can be taken along with other treatments for lung cancer, under supervision and with a doctor’s consultation.

Generally, the therapy is recommended when cancer blocks the airway resulting in a severe form of breathlessness. For instance, if the cancer is caught in the early stages, doctors may recommend photodynamic therapy (PTD) which uses lasers and light to treat the cancer cells that are restricted to the inner layer of the lung airways and have not spread to the outer layer.

In the case of laser therapy, large tumors that block the airway or tiny tumors that are present in the lung lining are burnt. Poor lifestyle choices or due to various other conditions like work-related diseases, air pollution, and second-hand smoke, amongst others have led to a drastic increase in the number of patients suffering from lung cancer.

As per the American Cancer Society, the estimated number of new lung cancer patients in 2022 is about 236,740 whereas the reported death occurring due to the same diseases totaled over 130,180. According to the same report, lung cancer is deemed the leading cause of death among all cancer forms, covering over 25% of deaths related to cancer. The rising innovations in the healthcare field are expected to help the market grow.

The high cost of pulmonology lasers may restrict the global market expansion whereas the growing research & development provide market growth opportunities. The absence of sufficient medical reimbursement policies to challenge market growth.

The global pulmonology lasers market is segmented based on laser type, indication, end-user, and region.

Based on laser type, the global market segments are photodynamic, and Nd-YAG. The global market generated the highest revenue from the Nd-YAG type, owing to the various benefits offered by the technology used in these lasers involving high energy output making it easy to achieve population inversion with this type. Although the price range of these lasers may somewhat be a restricting factor since as of 2018, the price of the laser was above USD 10,000.

Based on indication, the global market is divided into malignant lesions, neoplasms, bronchogenic carcinoma, tracheal stenosis, and hemorrhage. The global market is currently dominated by bronchogenic carcinoma which is generally associated with people who smoke. As per the American Cancer Society, more than 90% of men and 84% of women diagnosed with lung cancer either currently smoke or were smokers in the past. The growing number of lung cancer patients is expected to aid the segmental growth trend in the coming years

Based on end-users, the global market is divided into specialty care centers, hospitals, academic centers, and research organizations. Hospitals dominate the global market because of the advanced facilities and the complete treatment process available at hospitals. They also have the necessary funds to invest in high-costing equipment and their maintenance, which is a major reason for segmental growth. In a 2018 survey by Scorpion, 58% of the surveyed patients mentioned that they preferred hospitals near their place for treatment, while the rest 42% would prefer hospitals away from their residence.

The global pulmonology laser market is anticipated to be dominated by North America because of the advanced healthcare infrastructure as well as the constantly increasing investment in the healthcare sector to make quality medical treatment accessible to all. In 2018, the US government spent around USD 130 billion on healthcare research.

The countries in North America have set examples when it comes to medical reimbursement for medical cost-sharing between patients and government institutes which encourages people to opt for medical treatments without worrying about finances. Asia-Pacific is projected to grow at a high CAGR majorly due to the advancement in the healthcare region of China, Japan, and India. Among Japanese people, lung cancer has become an extremely common cause of death related to cancer. It has the third-highest prevalence among other cancers. Owing to such reasons, the governments in Asia-Pacific along with private hospitals and research companies are aiming toward empowering healthcare to treat such serious conditions.

The global pulmonology lasers market is dominated by players like Richard Wolf, Quanta System, Cook Medical, Convergent Laser Technologies, Hyper Photonics, Olympus Corporation, Edap Tms, Jena Surgical, Potent Medical, and Lumenis.

Recent Developments:

• In March 2022, Mauna Kea Technologies and On Target Laboratories announced a collaboration for novel clinical research and product development. The collaboration aims to help enhance the joint technological and clinical capabilities of both companies. The field chosen for the project is molecular image-guided procedures which are extremely useful in interventional and surgical procedures that help detect cancer cells with better visualization and with absolute ease.
• In October 2021, Mauna Kea Technologies presented 5 communications that highlighted the benefits of Cellvizio at the European Respiratory Society (ERS) International Congress. Cellvizio is a multidisciplinary probe and needle-based confocal laser endomicroscopy platform and is used in interventional pulmonology.

Browse the full “Pulmonology Lasers Market By Indication (Malignant Lesions, Neoplasms, Bronchogenic Carcinoma, Tracheal Stenosis, and Hemorrhage), By Laser Type (Photodynamic, and Nd-YAG), By End-Users (Specialty Care Centers, Hospitals, Academic Centers, and Research Organizations), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/pulmonology-lasers-market

The global pulmonology lasers market is segmented as follows:

By Indication

• Malignant Lesions
• Neoplasms
• Bronchogenic Carcinoma
• Tracheal Stenosis
• Hemorrhage

By Laser Type

• Photodynamic
• Nd-YAG

End-Users

• Specialty Care Centers
• Hospitals
• Academic Centers
• Research Organizations

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com